tbuckley/cabot-search huggingface dataset:
Veröffentlichungen aus der Gewerbe- und Konstitutionspathologie.
Journal: JAMA (1933)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Medicaid Managed Care: Contribution to Issues of Health Reform
Authors: D. A. Freund
Journal: Annual Review of Public Health (1995)

This chapter examines the emergence of managed care in Medicaid from an alternative to the mainstream delivery system for many beneficiaries. It offers a definition that encompasses the broad spectrum of program manifestations, and presents a brief historical perspective on the major eras of managed care in Medicaid, The major program prototypes are described and their contribution to enrollment growth is discussed. Research evidence is examined to address both operational issues and program impacts. Finally, we conclude with an appraisal of contemporary issues of importance and speculation on the next generation of Medicaid managed care programs with an eye to how federal and state health care reform proposals will shape this future.
THE OPHTHALMOSCOPE.
Journal: JAMA (1889)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Prevalence of Cigarette Use Among 14 Racial/Ethnic Populations—United States, 1999-2001
Journal: JAMA (2004)

The 1998 Surgeon General's report, Tobacco Use Among U.S. Racial/Ethnic Minority Groups, addressed diverse tobacco-control needs of the four primary U.S. racial/ethnic minority populations: non-Hispanic blacks, American Indians/Alaska Natives (AI/ANs), Asians/Pacific Islanders, and Hispanics. However, data on these populations do not describe differences in tobacco-use prevalence among subsets of these populations. To assess the prevalence of cigarette smoking among persons aged > or =12 years among 14 racial/ethnic populations in the United States, CDC analyzed self-reported data collected during 1999-2001 from the National Survey on Drug Use and Health (NSDUH) (formerly the National Household Survey on Drug Abuse). This report summarizes the results of that analysis, which indicated that the prevalence of cigarette smoking among adults aged > or =18 years ranged from 40.4% for AI/ANs to 12.3% for the Chinese population, and the prevalence among youths aged 12-17 years ranged from 27.9% for AI/ANs to 5.2% for the Japanese population. Implementing tobacco-control programs that include culturally appropriate interventions can help reduce tobacco use among racial/ethnic populations.
Donor selection limits use of living-related liver transplantation
Authors: John F. Renz, Chris L. Mudge, Melvin B. Heyman, Steve Tomlanovich, Ralph P. Kingsford, Barbara J. Moore, John D. Snyder, Hilary A. Perr, Amie L. Paschal, John P. Roberts, Nancy L. Ascher, Jean C. Emond
Journal: Hepatology (1995)

The purpose of this investigation was to assess the applicability of living-related liver transplantation in an established regional transplant program by determining the frequency of acceptable living donors from an unselected population of pediatric transplant candidates and identify specific factors limiting application of this technique. During the period May 1992 to May 1994, all children accepted as transplant candidates at the University of California-San Francisco were evaluated for potential living-related liver transplantation. Indications for transplantation and patient demographics represented the spectrum anticipated at a regional center. Donor evaluation was performed using a three-phase evaluation process we have previously reported. Retrospective analysis identified 75 potential donors for 38 pediatric candidates (age range, 17 days to 14.5 years; mean, 5.1 years). Twenty-three percent of potential donors declined evaluation. Of the 75 potential donors, only 10 (13%) were found to be acceptable for donation. The leading causes for donor declination were significant medical history (23%), ABO blood group incompatibility (23%), and psychosocial history (20%). Of the 38 recipient candidates, 9 (23%) were offered living-donor transplantation. Five patients have received living-donor transplantation, and 4 patients await the procedure when medical indications exist. Seventy-seven percent of recipient candidates received or are awaiting cadaveric transplantation. These results suggest that current donor criteria markedly limit the application of living-related liver transplantation. (Hepatology 1995; 22:1122-1126.).
Physicians and Acquired Immunodeficiency Syndrome
Authors: Barbara Gerbert
Journal: JAMA (1989)

Are patients concerned about going to a physician who is infected with human immunodeficiency virus (HIV) or one who is treating HIV-infected patients? To answer these questions, we surveyed a nationwide sample of 2000 interviews (response rate, 75%). Forty-five percent of all respondents believed that physicians who were HIV infected should not be allowed to continue to practice. More than half of those who had seen a physician in the past 5 years said they would change physicians if they knew their physician were HIV infected, while one fourth said they would seek care elsewhere if their physician were treating people with HIV disease. These data suggest that patients are concerned about HIV in their physicians' offices. The American Medical Association recommends that HIV-infected physicians continue to practice as long as there is no risk to their patients. Physicians and the public need to be educated about this policy and its appropriateness. (<i>JAMA</i>. 1989;262:1969-1972)
Energy expenditure with indoor exercise equipment
Authors: J. M. Rippe
Journal: JAMA (1996)

<h3>In Reply.</h3> —We hope the opinions of Dr Yannios and Dr Rippe that our article was "potentially counterproductive to promoting fitness" and "a disservice to the public" were not shared by other readers of<i>JAMA</i>. We are professionally devoted to exercise science research and clinical activities to help individuals improve fitness and function. We also believe that our mission as scientists is to carefully perform investigations examining testable hypotheses and to accurately report the results. Interpretation of the results by the media and by other professionals is beyond our control. Dr Yannios states that Saltin and Astrand<sup>1</sup>showed "V0<sub>2</sub>maximum at equivalent RPE's are highest in cross-country skiing, followed by running and cycling, then rowing." In actuality, that study was not a comparison of different exercise modes, but rather a comparison of maximal oxygen uptakes among different types of athletes. Additionally, RPE was not reported in this work nor
Paediatric Pathology
Authors: Stanley B. Smith
Journal: JAMA (1983)

The preface states that this book is directed to the individual with special interest in pediatric pathology, rather than to one with special training. The author points out that it is not intended as a comprehensive text or as a reference volume. The book is printed on high-quality paper. Most of the illustrations, charts, tables, and diagrams are excellent. The book is well organized, with most chapters having a similar organization—embryology and development are covered, followed by a discussion of disease states. The introductory chapter on examination of the fetus is a good introduction to the subject and should be of use to the beginning pathology resident and as a refresher to the general pathologist who performs an occasional autopsy on an infant. The brief introduction to nonaccidental injury should be read by all first-year residents in pathology. The sections on the placenta and heart are well done. The lung
An Antifibrinolytic Agent
Journal: JAMA (1965)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Spinal Cord Injury Network
Journal: JAMA (1995)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
AN ADAMLESS EDEN.THE CENSUS AND MORTALITY STATISTICS.MYOSITIS OSSIFICANS.
Journal: JAMA (2000)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Chronic Acral Dermatitis
Authors: Richard K. Winkelmann
Journal: JAMA (1973)

Three patients with a pruritic, papulovesicular, and keratotic dermatitis of the hands, feet, and extremities had markedly elevated serum IgE levels up to 100,000 ng/ml. There was no personal or family history of atopic disease. A variety of immunologic, physiologic, and pharmacologic studies of the skin had normal results. Mast cells were observed in large numbers in the dermis and even in the epidermis. The course of this unique dermatitis is chronic, lasting many years, and it is resistant to all treatments except administration of corticosteroid drugs.
FOREIGN-BODY INGESTION
Journal: JAMA (1964)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Hispanic health in the United States. Council on Scientific Affairs
Journal: JAMA (1991)

Hispanics are the fastest growing minority in the United States. Typically, they are divided into five subgroups: Mexican American, Puerto Rican, Cuban American, Central or South American, and "other" Hispanics. Risk factors for morbidity and mortality vary among these subgroups. Use of health care services is affected by perceived health care needs, insurance status, income, culture, and language. Compared with whites, Hispanics are more likely to live in poverty, be unemployed or underemployed, and have little education and no private insurance. Hispanics are at an increased risk for certain medical conditions, including diabetes, hypertension, tuberculosis, human immunodeficiency virus infection, alcoholism, cirrhosis, specific cancers, and violent deaths. Proportionate to their representation in the population, there are few Hispanic health providers, emphasizing the need for all medical personnel to be knowledgeable about Hispanic health care needs.
Lenalidomide, Bortezomib, and Dexamethasone (RVD) In Combination with Vorinostat as Front-Line Therapy for Patients with Multiple Myeloma (MM): Initial Results of a Phase 1 Study
Authors: Jonathan L. Kaufman, Jatin J Shah, Jacob P. Laubach, Leonard Heffner, Dixil Francis, R. Donald Harvey, Colleen Lewis, Mourad Tighiouart, Paul Richardson, Robert Z. Orlowski, Sagar Lonial
Journal: Blood (2010)
The prevalence of psychological comorbidity in people with vitiligo: a systematic review and meta-analysis
Authors: O. Osinubi, M.J. Grainge, L. Hong, A. Ahmed, J.M. Batchelor, D. Grindlay, A.R. Thompson, S. Ratib
Journal: British Journal of Dermatology (2018)

Summary Vitiligo is a long-term condition where pale white patches develop on the skin. It's caused by a lack of melanin, a pigment (colour) in the skin. People of any age, skin type and gender can develop vitiligo and it can affect any area of skin. It is estimated that about 1 in 100 people around the world has vitiligo. The researchers who conducted this study are based in Nigeria and the UK. Our study aimed to find out how commonly psychological symptoms such as depression and anxiety occur in people in vitiligo, by looking at all relevant published studies from around the world. After extracting data from 29 studies published in this area we found that people living with vitiligo experience a range of psychological symptoms or disorders. Approximately one in four people with vitiligo appear to have depression and at least one in seven have anxiety. However, they were significantly less likely to show symptoms of depression than people with psoriasis. We also found that there were many tools to measure psychological outcomes (the emotional impact) in skin diseases, and more work needs to be done to develop tools which can be used in people with vitiligo. Our conclusion is that assessment of psychological state during clinical evaluation of vitiligo patients, as suggested by the British Association of Dermatologists’ guidelines, is essential. The same can be said for clinical evaluation of people with other skin conditions.
THE REPORT OF THE FRENCH YELLOW-FEVER COMMISSION.
Journal: JAMA (1904)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Cancer of the gastrointestinal tract. I. Esophagus: detection and diagnosis
Authors: P. Rubin
Journal: JAMA (1973)

The malignancy gradient of alimentary tract cancer increases as it ascends from the colon to the esophagus. The mortality and morbidity associated with tumors of the esophagus exceed that which is associated with lung cancer. Fortunately, esophageal cancer is not common in this country. Its incidence is highest in Japan, where 46.3 men per 100,000 men over 35 years of age are afflicted, compared to 10 men per 100,000 men in the United States.<sup>1</sup>It is primarily a disease of men, with a sex ratio of 3:1; but women account for 40% to 50% of esophageal cancer in Sweden and Finland. Certain conditions (ie, Plummer-Vinson syndrome) are associated with higher incidence, but the cause is obscure. Achalasia or hiatus hernia are more tenuously related.<sup>2</sup> Reprints are not available. Cancer of the esophagus is rarely detected with screening procedures during its asymptomatic phase when it is localized. There is
Abstract 18299: Device Selection: Does Ventricular Size Matter in LVAD Recipients?
Authors: Palak Shah, Simon Maltais, Meng Xu, Shashank S Desai, Ramesh Singh, Nicholas A Haglund, Shannon M Dunlay, John M Stulak, Keith D Aaronson, Mary B Davis, Christopher Salerno, Francis D Pagani, Jennifer A Cowger
Journal: Circulation (2015)

Introduction: Axial and centrifugal-flow left ventricular assist devices (LVAD) have varied response to changes in loading conditions. Whether ventricular size modulates the response to LVAD therapy between the axial flow Heartmate II (HMII) and centrifugal flow Heartware (HVAD) is unknown. Hypothesis: Adverse event and survival rates between devices are affected by recipient pre-op left ventricular end-diastolic diameter (LVEDD). Methods: Data on 1,149 continuous-flow LVAD recipients from May 2004 to May 2015 was pooled from the Mechanical Circulatory Support Research Network (MCSRN). The effect of pre-op LVEDD on the instantaneous hazard of death and adverse events was evaluated between HMII (n=864) and HVAD (n=283). Results: The average LVEDD was 7.0cm and did not differ between the device recipients. Patients with a smaller LVEDD (≤ 6.3cm) were more likely female 39% v. 24% (p &lt; 0.0001) and to have an ischemic cardiomyopathy (30% v. 24%, p = 0.045). For every 1cm increase in pre-op LVEDD, the adjusted hazard ratio (HR) for mortality increased with HVAD (HR 1.31, 95% CI 0.94-1.82, p = 0.005) and decreased with HMII (HR 0.78, 95% CI 0.67-0.92, p = 0.005), Figure 1a. Other predictors of mortality included age (HR 1.31, 95% CI 1.12 - 1.53 per 10y, p &lt; 0.001) and bilirubin (HR 1.15, 95% CI 0.94-1.42 per mg/dL, p = 0.027). LVEDD by device type interaction was not a significant predictor of gastrointestinal bleeding or pump thrombosis. The risk of stroke increased with LVEDD for HVAD and decreased for HMII, but this did not reach statistical significance, Figure 1b. Ischemic etiology of heart failure (HR 1.7 95% CI 1.14 - 2.55, p = 0.01) and HVAD device use (HR 1.47 95% CI 1.00 - 2.17, p = 0.03) were significant predictors of stroke. Conclusions: Our data suggest important differences exist in patient outcomes between HMII and HVAD based on pre-op ventricular size. Studies are needed to determine if these differences in outcome are due to device or flow-specific differences in patient support.